193360-38-2

Upstream product

• 193360-44-0 3-azidopropyl trifluoromethanesulfonate 
• 193360-36-0 ((4S,5R,6R)-4-Benzyloxy-6-hydroxymethyl-3-iodo-5-methoxy-tetrahydro-pyran-2-yloxy)-acetic acid methyl ester 
• 87316-22-1 (2R,3S,4R)-2-(((tert-butyldiphenylsilyl)oxy)methyl)-3,4-dihydro-2H-pyran-3,4-diol 
• 100-39-0 benzyl bromide 
• 193360-22-4 (2R,3S,4R)-4-Benzyloxy-2-(tert-butyl-diphenyl-silanyloxymethyl)-3,4-dihydro-2H-pyran-3-ol 
• 193360-24-6 ((2R,3S,4R)-4-Benzyloxy-3-methoxy-3,4-dihydro-2H-pyran-2-ylmethoxy)-tert-butyl-diphenyl-silane 
• 193360-34-8 [(4S,5R,6R)-4-Benzyloxy-6-(tert-butyl-diphenyl-silanyloxymethyl)-3-iodo-5-methoxy-tetrahydro-pyran-2-yloxy]-acetic acid methyl ester 

Downstream Products

• 193360-45-1 [(2S,3S,4S,5R,6R)-6-(3-Amino-propoxymethyl)-4-benzyloxy-3-iodo-5-methoxy-tetrahydro-pyran-2-yloxy]-acetic acid 
• 193360-39-3 [(2S,3S,4S,5R,6R)-6-(3-Amino-propoxymethyl)-4-benzyloxy-3-iodo-5-methoxy-tetrahydro-pyran-2-yloxy]-acetic acid methyl ester 

Relevant academic research and scientific papers

Design, synthesis and biological evaluation of carbohydrate-based mimetics of cRGDFV

The design, synthesis and preliminary biological evaluation of carbohydrate-based non-peptide mimetics of the potent peptidic antagonist of α(v)β3 and α(v)β5, pentapeptide cRGDFV (1) is presented. The design was based on the NMR-determined structure of 1.